Sept 21 (Reuters) – Australia’s Telix Pharmaceuticals said on Monday it has agreed to acquire Germany-based ITM Isotope Technologies Munich SE for about $1.65 billion on a cash- and debt-free basis.
After adjustments, ITM shareholders are expected to receive about $1.25 billion in Telix shares at $11.84 per share.
(Reporting by Sneha Kumar in Bengaluru; Editing by Aurora Ellis)
Brought to you by www.srnnews.com
SRN News — View the original story at SRNNews.com.
